Esophageal Cancer: Should Gender Be Considered as an Influential Factor for Patient Safety in Drug Treatment?
Aim. Analyze the gender difference of esophageal cancer patients in response to drug treatment. Methods. All publications on clinical trials were collected from PubMed, Scopus, and PMC. Each publication was examined to determine whether the publication is a clinical trial and whether data on gender...
Main Authors: | Fengxia Liu, Helin Feng, Sumin Guo, Yuhan Chen, Qingyi Liu, Feng Wu, Weikuan Gu, Baoen Shan |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2019-01-01
|
Series: | Journal of Oncology |
Online Access: | http://dx.doi.org/10.1155/2019/6340567 |
Similar Items
-
From Anti-PD-1/PD-L1 to CTLA-4 and to MUC1—Is the Better Response to Treatment in Smokers of Cancer Patients Drug Specific?
by: Lishi Wang, et al.
Published: (2021-09-01) -
Drug discovery for Chagas disease should consider Trypanosoma cruzi strain diversity
by: Bianca Zingales, et al.
Published: (2014-09-01) -
Asymptomatic Esophageal Varices Should Be Endoscopically Treated
by: Nib Soehendra
Published: (1998-01-01) -
Identification High Influential Articles by Considering the Topic Characteristics of Articles
by: Mingyang Wang, et al.
Published: (2020-01-01) -
Emotion Elicitation Under Audiovisual Stimuli Reception: Should Artificial Intelligence Consider the Gender Perspective?
by: Marian Blanco-Ruiz, et al.
Published: (2020-11-01)